Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Cassandra A Hathaway"'
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2489-2495 (2021)
ABSTRACT Background Increasing evidence, including multiple putative inflammatory risk factors (e.g., c‐reactive protein, and adiposity), supports that inflammation plays an important role in ovarian carcinogenesis. Resistance training (RT) is asso
Externí odkaz:
https://doaj.org/article/b8cd0e91e298475cafad8f703496812d
Autor:
Cassandra A Hathaway, Melody N Chavez, Mika Kadono, Dana Ketcher, Dana E Rollison, Erin M Siegel, Anita R Peoples, Cornelia M Ulrich, Frank J Penedo, Shelley S Tworoger, Brian D Gonzalez
Publikováno v:
JMIR Cancer, Vol 7, Iss 3, p e30265 (2021)
BackgroundSurveys play a vital role in cancer research. During the COVID-19 pandemic, the use of electronic surveys is crucial to improve understanding of the patient experience. However, response rates to electronic surveys are often lower compared
Externí odkaz:
https://doaj.org/article/ddf1d4550fc64840a2909790b6539f34
Autor:
Cassandra A Hathaway, Erin M Siegel, Christine H Chung, Smitha Pabbathi, Jennifer Vidrine, Susan Vadaparampil, Shelley S Tworoger
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246686 (2021)
Patients consented to biobanking studies typically do not specify research conducted on their samples and data. Our objective was to gauge cancer biobanking participant preferences on research topics. Patient-participants of a biobanking study at a c
Externí odkaz:
https://doaj.org/article/749a452e593640dabdf04ecccd3ec84b
Autor:
Cassandra A. Hathaway, Jose R. Conejo-Garcia, Brooke L. Fridley, Bernard Rosner, Daryoush Saeed-Vafa, Carlos Moran Segura, Jonathan V. Nguyen, Jonathan L. Hecht, Naoko Sasamoto, Kathryn L. Terry, Shelley S. Tworoger, Mary K. Townsend
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:848-853
Background: Despite the immunogenic nature of many ovarian tumors, treatment with immune checkpoint therapies has not led to substantial improvements in ovarian cancer survival. To advance population-level research on the ovarian tumor immune microen
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer
Autor:
Cassandra A. Hathaway, Erin M. Siegel, Brian D. Gonzalez, Laura B. Oswald, Anita R. Peoples, Cornelia M. Ulrich, Frank J. Penedo, Shelley S. Tworoger, Jessica Y. Islam
Publikováno v:
Vaccine. 40:6649-6657
Vaccine hesitancy in the wake of the COVID-19 pandemic is a major public health concern in the US. Cancer patients are especially vulnerable to adverse COVID-19 outcomes and require targeted prevention efforts against COVID-19.We used longitudinal su
Autor:
Cassandra A. Hathaway, Tianyi Wang, Mary K. Townsend, Christine Vinci, Danielle E. Jake-Schoffman, Daryoush Saeed-Vafa, Carlos Moran Segura, Jonathan V. Nguyen, Jose R. Conejo-Garcia, Brooke L. Fridley, Shelley S. Tworoger
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:66-73
Background: Exposure to cigarette smoke, particularly in early life, is modestly associated with ovarian cancer risk and may impact systemic immunity and the tumor immune response. However, no studies have evaluated whether cigarette smoke exposure i
Autor:
Song Yao, Peter T. Campbell, Tomotaka Ugai, Gretchen Gierach, Mustapha Abubakar, Viktor Adalsteinsson, Jonas Almeida, Paul Brennan, Stephen Chanock, Todd Golub, Samir Hanash, Curtis Harris, Cassandra A. Hathaway, Karl Kelsey, Maria Teresa Landi, Faisal Mahmood, Christina Newton, John Quackenbush, Scott Rodig, Nikolaus Schultz, Guillermo Tearney, Shelley S. Tworoger, Molin Wang, Xuehong Zhang, Montserrat Garcia-Closas, Timothy R. Rebbeck, Christine B. Ambrosone, Shuji Ogino
Publikováno v:
Cancer Causes & Control. 33:1107-1120
Cancer heterogeneities hold the key to a deeper understanding of cancer etiology and progression and the discovery of more precise cancer therapy. Modern pathological and molecular technologies offer a powerful set of tools to profile tumor heterogen
Autor:
Mary K. Townsend, Shelley S. Tworoger, Kathryn L. Terry, Naoko Sasamoto, Jonathan L. Hecht, Jonathan V. Nguyen, Carlos Moran Segura, Daryoush Saeed-Vafa, Bernard Rosner, Brooke L. Fridley, Jose R. Conejo-Garcia, Cassandra A. Hathaway
Supplemental Table 1 shows the correlations of percentages of the markers in the tumor.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799bbb155c590620add1200809abdebc
https://doi.org/10.1158/1055-9965.22593370
https://doi.org/10.1158/1055-9965.22593370
Autor:
Mary K. Townsend, Shelley S. Tworoger, Kathryn L. Terry, Naoko Sasamoto, Jonathan L. Hecht, Jonathan V. Nguyen, Carlos Moran Segura, Daryoush Saeed-Vafa, Bernard Rosner, Brooke L. Fridley, Jose R. Conejo-Garcia, Cassandra A. Hathaway
Supplemental Figure 1 provides representative images from the T cell panel for high-grade serous, endometrioid, clear cell, and mucinous tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910ab62f439760eb3afcc2c9a9cde64a
https://doi.org/10.1158/1055-9965.22593376
https://doi.org/10.1158/1055-9965.22593376
Autor:
Mary K. Townsend, Shelley S. Tworoger, Kathryn L. Terry, Naoko Sasamoto, Jonathan L. Hecht, Jonathan V. Nguyen, Carlos Moran Segura, Daryoush Saeed-Vafa, Bernard Rosner, Brooke L. Fridley, Jose R. Conejo-Garcia, Cassandra A. Hathaway
Supplemental Figure 2 provides representative images from the immune checkpoint panel for high-grade serous, endometrioid, clear cell, and mucinous tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bcc91d4411ed7b8fa6b08ca5cc783ea
https://doi.org/10.1158/1055-9965.22593373
https://doi.org/10.1158/1055-9965.22593373